Control of myocardial oxygen consumption: physiologic and clinical considerations

Am J Cardiol. 1971 Apr;27(4):416-32. doi: 10.1016/0002-9149(71)90439-5.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Adrenergic beta-Antagonists / pharmacology
  • Angina Pectoris / metabolism
  • Angina Pectoris / physiopathology
  • Animals
  • Blood Pressure
  • Calcium / pharmacology
  • Cardanolides / pharmacology
  • Cardiac Output
  • Carotid Sinus / physiology
  • Catecholamines / pharmacology
  • Cats
  • Digitalis Glycosides / pharmacology
  • Dogs
  • Electric Stimulation
  • Heart / physiology
  • Heart Conduction System / physiopathology
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Heart Rate
  • Heart Valve Diseases / metabolism
  • Heart-Lung Machine
  • Humans
  • Muscle Contraction
  • Myocardial Infarction / metabolism
  • Myocardium / metabolism*
  • Norepinephrine / pharmacology
  • Oxygen Consumption* / drug effects
  • Papillary Muscles / metabolism
  • Phosphates / metabolism
  • Propranolol / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Cardanolides
  • Catecholamines
  • Digitalis Glycosides
  • Phosphates
  • Adenosine Triphosphate
  • Propranolol
  • Calcium
  • Norepinephrine